Palmitoyl Tetrapeptide-7 (Pal-GQPR)
Palmitoyl Tetrapeptide-7 is a synthetic matrikine peptide that reduces skin inflammation and supports matrix stability. It combines the GQPR sequence with a palmitoyl group to improve skin penetration. As a
Encapsulated system of azelaic acid (4–6%) and palmitoyl tripeptide-36 in biodegradable PCL microspheres. Provides controlled release, improved tolerance, and boosted stability. Targets acne, uneven tone, redness, and post-blemish marks while supporting smoother texture and antioxidant defense. Water-dispersible, recommended at 3–5% in gels, serums, and light creams.
Palmitoyl Tetrapeptide-7 is a synthetic matrikine peptide that reduces skin inflammation and supports matrix stability. It combines the GQPR sequence with a palmitoyl group to improve skin penetration. As a
This encapsulated complex targets hyperpigmentation, gently exfoliates to refine texture, and soothes irritation—promoting a calmer, brighter, and more even complexion. Encapsulation enhances stability and skin compatibility, making it ideal for
Actives™ B-TOX blends advanced peptides to reduce wrinkles and restore firmness. Acetyl hexapeptide-8 relaxes facial muscles, while Palmitoyl pentapeptide-4 stimulates collagen production. Together, they smooth expression lines and improve skin